Liu Lina 4
4 · Yubo International Biotech Ltd · Filed Jan 20, 2021
Insider Transaction Report
Form 4
Liu Lina
Chief Financial Officer
Transactions
- Disposition to Issuer
Class A Common Stock
[F1]2021-01-14−116,697,438→ 0 total - Purchase
Class A Common Stock
[F2][F3]2021-01-14+13,829,400→ 13,829,400 total(indirect: By Focus Draw Group)
Footnotes (3)
- [F1]The shares reported herein were surrendered to the issuer and canceled in connection with an exchange transaction by and among Platinum International Biotech Co., Ltd.("Platinum"),Yubo International Biotech (Beijing) Limited, the Reporting Person and certain other stockholders of Platinum. No cash consideration was paid in connection with surrender and cancellation of the shares.
- [F2]The shares reported herein were acquired in connection with an exchange transaction by and among Platinum International Biotech Co., Ltd. ("Platinum"), Yubo International Biotech (Beijing) Limited, the Reporting Person and certain other stockholders of Platinum. The Issuer issued the shares reported herein to the Reporting Person in exchange for the Reporting Person's equity interest in Platinum. No cash consideration was paid in connection with the exchange transaction.
- [F3]The shares are held by Focus Draw Group, of which the reporting person is the sole director. The Reporting Person disclaims beneficial ownership of the securities except to the extent of her pecuniary interest therein.
Signature
/s/ Lina Liu, CFO, Treasurer and Secretary|2021-01-20